The deal involves the implementation into Limbach Group labs of Noul's automated MiLab instrument that uses microscopy and AI-developed algorithms to analyze samples.

NEW YORK – Altona Diagnostics said on Thursday that it has received the European Union's In Vitro Diagnostic Regulation certification for the company's PCR-based tests, and the company plans to launch ...

The funding will support the development of the AmplifiDx Dx 100 Platform for use with a nucleic acid amplification test for respiratory infections.

The US Food and Drug Administration granted clearances to tests for infectious diseases, drug resistances, and chronic diseases, among other clearances.

The organization now recommends HPV primary screening every five years starting at age 30 and includes patient-collected HPV screening.

Last week, readers were most interested in a story about efforts by a new organization to get Congress to pass legislation revamping oversight of LDTs.

The firm said its T2 Magnetic Resonance technology for testing whole-blood samples could be paired with fluorescence and other testing methods.

The funding will allow 52North to move its products, including its Neutrocheck point-of-care device, toward commercialization.

Last week, readers were most interested in a story about Agilent changing two of its three business organizations to accelerate growth.

The awards will support the development of US Food and Drug Administration-cleared tests for Marburg virus and Burkholderia pseudomallei infection.

Out of the 30 companies tracked by 360Dx, 13 saw their share prices increase, while 17 saw their stock prices decline.